Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc.

TPST
Tempest Therapeutics, Inc.US flagNASDAQ Capital Market
0.99
USD
+0.04
- -
4.40MMarket Cap

Tempest Therapeutics, Inc. (TPST) Stock Split History

Learn about Tempest Therapeutics, Inc.'s most recent 1-for-13 basis stock split on April 09, 2025. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Tempest Therapeutics, Inc.'s most recent stock split

Split Date: 2025-04-09
Split Ratio: 1:13
Price Before Split: $0.55
Price After Split: $0.04

Developer API

Get TPST split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/TPST

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 13.00 times fewer shares (a 1:13 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Tempest Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-04-091:13Yes$0.55$0.04
2021-06-281:15Yes$0.89$0.06
2018-12-101:15Yes$0.67$0.04

About Tempest Therapeutics, Inc.

Company overview and industry information

Tempest Therapeutics, Inc. (TPST) operates in the Biotechnology industry. The recent 1-for-13 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Tempest Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.